PRECISION VIROLOGICS INC
Dendritic cell-targeting Adenovirus-based vaccine platform against Chikungunya virus
- Sector
- Biotech
- Headquarters
- Saint Louis, MO
- Founded
- 2016
- Latest Form D
- $500K, Apr 2017
- Total capital
- $1.4M
- Federal grants
- $935K
- 4 awards · 2018–2019
- Rank in peer group#8 of 392
- Private capital raised
- $500K
- 1 Form D · last Apr 2017
- 114 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Biologically Targeted Vaccine for Chikungunya$300K
- Federal grantHealth and Human S · Phase I · Biologically Targeted Vaccine for Chikungunya$300K
- Federal grantHealth and Human S · Phase I · ConProject-001$120K
- Federal grantHealth and Human S · Phase I · In Vivo Editing for Hemophilia Gene Therapy$215K
- Private capital raisedForm D · SEC · 1st filing$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grants#8 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Daniel E. KatzmanExecutive Officer, DirectorNamed in SEC Form D filings
- David T CurielExecutive Officer, DirectorNamed in SEC Form D filings
- Yasunari E. KashiharaDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingDendritic Cell Targeted Adenovirus For VaccinationUSPTOApplication PCTUS2018029900
- PendingDendritic Cell Targeted Adenovirus for VaccinationUSPTOApplication 62490764
Related companies, and why
- Soteria Biotherapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- GENERAL BIOPHYSICS, LLCSimilar federal contract value in Biotech · null in contracts
- Enzyme by Design Inc.Similar federal contract value in Biotech · null in contracts
- DiaMedica Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- DURAVAX INCSimilar federal contract value in Biotech · null in contracts
- DISCOVERY LABORATORIES, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .